Inactive Instrument
Sector Aviragen Therapeutics Inc Nasdaq
Stocks
US0906941002
Biotechnology & Medical Research
|
End-of-day quote
Nasdaq
|
||
| - USD | - |
|
| 08/08 | Vaxart, Inc., Q2 2026 Earnings Call, Aug 07, 2026 | |
| 07/08 | Vaxart, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +2.07% | +13.76% | +35.00% | +49.04% | +79.09% | +65.44% | +106.53% | +17.00% | - | 70.1B | |
| -0.87% | +0.08% | -0.68% | +9.78% | +5.25% | +36.96% | +65.91% | +182.97% | +5,422.69% | 54.93B | |
| -4.50% | -4.69% | +15.75% | +7.07% | -27.41% | +2.82% | +463.22% | +436.21% | +960.71% | 28.89B | |
| -1.44% | -1.74% | +17.96% | +38.05% | +43.32% | +46.20% | +5.90% | -62.76% | - | 23.9B | |
| -0.67% | +1.02% | +2.28% | -0.12% | -3.24% | -18.32% | -13.84% | -75.59% | - | 23.3B | |
| -0.59% | +7.88% | +6.38% | +20.25% | -0.10% | +40.87% | -20.56% | -31.36% | +78.89% | 18.77B | |
| +0.35% | +12.02% | +15.60% | +104.98% | +241.04% | +257.19% | +466.50% | +1,776.37% | +864.12% | 18.41B | |
| -1.52% | -4.08% | +3.87% | +19.02% | +31.95% | +19.35% | +608.90% | - | - | 16.1B | |
| +0.46% | -3.05% | -9.69% | -1.33% | +15.47% | +31.49% | +135.18% | +176.86% | +374.77% | 12.48B | |
| -5.38% | -0.59% | -4.45% | -2.22% | -12.87% | +35.86% | +195.96% | +497.89% | +6,637.98% | 12.39B | |
| -1.90% | -0.28% | +15.49% | +9.90% | +28.92% | +328.16% | +196.67% | +41.42% | +1,336.07% | 12.32B | |
| -7.28% | +3.40% | -8.50% | -25.49% | -19.95% | -47.90% | +713.95% | +76.77% | +110.18% | 12.05B | |
| -6.08% | -2.70% | +1.51% | -21.41% | -13.89% | -40.74% | +189.58% | +122.91% | - | 11.98B | |
| -2.90% | -9.73% | -10.69% | -4.88% | +15.60% | +99.16% | +124.27% | +128.46% | +504.53% | 10.52B | |
| -2.15% | -1.52% | +8.66% | +33.47% | +210.90% | +485.34% | +714.80% | -32.44% | -11.44% | 9.18B | |
| -2.18% | -6.43% | -2.18% | -10.28% | +12.08% | +4.20% | +120.19% | -22.78% | - | 8.99B | |
| -0.02% | +0.62% | +0.92% | +125.29% | +81.40% | +180.62% | +411.29% | +279.34% | - | 8.96B | |
| -1.32% | -0.05% | +3.21% | +8.50% | +27.57% | +86.56% | +24.68% | +126.12% | - | 8.88B | |
| -1.16% | +4.51% | -1.80% | -6.13% | +286.36% | +171.28% | +318.03% | -32.00% | - | 8.2B | |
| Average | -1.95% | +2.64% | +4.67% | +18.60% | +52.71% | +93.92% | +254.06% | +200.30% | +1,627.85% | 19.49B | |
| Weighted average by Cap. | -1.21% | +3.13% | +10.05% | +23.03% | +44.46% | +71.10% | +202.96% | +192.48% | +2,384.61% |
- Stock Market
- Stocks
- VXRT Stock
- Stock
- Sector Aviragen Therapeutics Inc
Select your edition
All financial news and data tailored to specific country editions
